McKesson Corporation (MCK)
After hours:
| Previous Close | 251.84 |
| Open | 252.44 |
| Bid | 247.38 x 1000 |
| Ask | 290.00 x 900 |
| Day's Range | 245.74 - 252.44 |
| 52 Week Range | 169.34 - 256.85 |
| Volume | |
| Avg. Volume | 961,283 |
| Market Cap | 37.654B |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -30.59 |
| Earnings Date | Feb. 02, 2022 |
| Forward Dividend & Yield | 1.88 (0.75%) |
| Ex-Dividend Date | Nov. 30, 2021 |
| 1y Target Est | 286.31 |
- Zacks
Here is Why Growth Investors Should Buy McKesson (MCK) Now
McKesson (MCK) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Should Value Investors Buy These Medical Stocks?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Business Wire
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
IRVING, Texas, January 18, 2022--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022. McKesson expects that the board will appoint Hinton to the Compliance Committee and Governance Committee and Wilson-Thompson to the Compensation Committee and Governance Committee. With the election of Hinton and Wilson-Thompson, McKesson’s board of directors increases from 9 to 11 members.
